ResMed (RMD) PT Lowered to $290 at KeyBanc
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $219.69 +3.66%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 38 | New: 37
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 38 | New: 37
Join SI Premium – FREE
KeyBanc analyst Brett Fishbin lowered the price target on ResMed (NYSE: RMD) to $290.00 (from $302.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Power Solutions (PSIX) to Buy
- National Energy Services Reunited (NESR) PT Raised to $40 at BTIG
- Jade Biosciences (JBIO) PT Raised to $47 at Wedbush
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
KeyBanc, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
